HBF-0079

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHBF-0079
Drug Alias NameHBF-0079
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A degraders
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaruch S. Blumberg Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnantigen Therapeutics IncBaruch S. Blumberg Institute
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A